Skip to main content

Advertisement

SpringerLink
Log in

Quality of life in a prospective, randomised pilot-trial of photodynamic therapy versus full macular translocation in treatment of neovascular age-related macular degeneration — a report of 1 year results

  • Retinal disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To assess visual function and its effects on vision-targeted, health-related quality of life (QOL) of patients with neovascular age-related macular degeneration (AMD) treated with photodynamic therapy (PDT) or full macular translocation (FMT).

Methods

Fifty patients with predominantly classic subfoveal choroidal neovascularisation (CNV) secondary to AMD were randomised to PDT or FMT. To test the vision-targeted QOL, the 39-item National Eye Institute Visual Function Questionnaire (NEI-VFQ-25 plus supplement) was administered prior to and 1 year after therapy. The change of vision-related QOL at 1 year in comparison to baseline was defined as primary end point.

Results

The vision-related subscales showed a stabilisation or even higher mean scores at 1 year in both treatment groups. A significant improvement in the quality of the subject’s vision-related subscales was only observed after FMT correlating with a more frequent increase in visual acuity. Comparing the results of the QOL scores after 1 year, the improvement of the subscale scores general vision (p = 0.03), mental health (p = 0.02) and dependency (p = 0.03) were significantly higher in the FMT arm.

Conclusions

FMT and PDT can achieve a stabilisation in vision-related QOL, in which FMT was superior to the PDT after 1 year. The discrepancy between the amount of patients with an increased visual acuity after FMT and a moderate improvement in QOL might be caused by the onset of complications related to this surgical procedure. Besides visual acuity, the impact of therapy-related complications has to be taken into consideration when evaluating new therapeutic concepts in exudative AMD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Klein R, Klein BE, Linton KL (1992) Prevalence of age-related maculopathy. The beaver dam eye study. Ophthalmology 99:933–943

    PubMed  CAS  Google Scholar 

  2. Treatment of Age-related Macular Degeneration with Photodynamic Therapy Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials—TAP report 1. Arch Ophthalmol 117:1329–1345

    Google Scholar 

  3. Treatment of Age-related Macular Degeneration with Photodynamic Therapy Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials—TAP report 2. Arch Ophthalmol 119:198–207

    Google Scholar 

  4. Treatment of Age-related Macular Degeneration with Photodynamic Therapy Study Group (2002) Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials—TAP report no. 5. Arch Ophthalmol 120:1307–1314

    Google Scholar 

  5. American Academy of Ophthalmology (2000) Macular translocation. Ophthalmology 107:1015–1018

    Article  Google Scholar 

  6. Abdel-Meguid A, Lappas A, Hartmann K, Auer F, Schrage N, Thumann G, Kirchhof B (2003) One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration. Br J Ophthalmol 87:615–621

    Article  PubMed  CAS  Google Scholar 

  7. Mruthyunjaya P, Stinnett SS, Toth CA (2004) Change in visual function after macular translocation with 360° retinectomy for neovascular age-related macular degeneration. Ophthalmology 111:1715–1724

    Article  PubMed  Google Scholar 

  8. Hewitt AW, Jeganathan SV, Kidd JE, Pesudovs K, Verma N (2006) Influence of photodynamic therapy for age related macular degeneration upon subjective vision related quality of life. Graefes Arch Clin Exp Ophthalmol 244(8):972–977

    Article  PubMed  Google Scholar 

  9. Armbrecht AM, Aspinall PA, Dhillon B (2004) A prospective study of visual function and quality of life following PDT in patients with wet age related macular degeneration. Br J Ophthalmol 88:1270–1273

    Article  PubMed  CAS  Google Scholar 

  10. Cahill MT, Stinnett SS, Banks AD, Freedman SF, Toth CA (2005) Quality of life after macular translocation with 360° peripheral retinectomy for age-related macular degeneration. Ophthalmology 112:144–151

    Article  PubMed  Google Scholar 

  11. Gelisken F, Voelker M, Schwabe R, Besch D, Aisenbrey S, Szurman P, Grisanti S, Herzau V, Bartz-Schmidt KU (2007) Full macular translocation versus photodynamic therapy with verteporfin in treatment of neovascular age-related macular degeneration: 1 year results of a prospective, controlled, randomised pilot- trial (FMT-PDT). Graefes Arch Clin Exp Ophthalmol [OnlineFirst 12 January 2007]

  12. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD, National Eye Visual Function Questionnaire Field Test Investigators (2001) Development of the 25-item national eye institute visual function questionnaire. Arch Ophthalmol 119:1050–1058

    PubMed  CAS  Google Scholar 

  13. Stelmack JA, Stelmack TR, Massof RW (2002) Measuring low-vision rehabilitation outcomes with the NEI VFQ-25. Invest Ophthalmol Vis Sci 43:2859–2868

    PubMed  Google Scholar 

  14. Clemons TE, Chew EY, Bressler SB, McBee W for the AREDS Research Group (2003) National eye institute visual function questionnaire in the age-related eye disease study (AREDS). Arch Ophthalmol 121:211–217

    PubMed  Google Scholar 

  15. Mangione CM, Berry S, Spritzer K (1998) Identifying the content area for the 51-item national eye institute visual function questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol 116:227–233

    PubMed  CAS  Google Scholar 

  16. Franke GH, Esser J, Voigtländer A, Mähner N (1998) Der National Eye Institute Visual Function Questionnaire (NEI-VFQ) — Erste Ergebnisse zur psychometrischen Überprüfung eines Verfahrens zur Erfassung der Lebensqualität bei Sehbeein- trächtigten. Z Med Psychol 7:178–184

    Google Scholar 

  17. Mangione CM (2000) The NEI VFQ-25 scoring algorithm. http://catalog.nei.nih.gov/productcart/pc/viewPrd.asp?idcategory=50&idproduct=60#). Cited 26 February 2007

  18. Cahill MT, Banks AD, Stinnett SS, Toth CA (2005) Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology 112(1):152–158

    Article  PubMed  Google Scholar 

  19. The Submacular Surgery Trials Research Group (2003) Responsiveness of the national eye institute visual function questionnaire to changes in visual acuity. Findings in patients with subfoveal choroidal neovascularization — SST report no. 1. Arch Ophthalmol 121:531–539

    Article  Google Scholar 

  20. Michels S, Schmidt-Erfurth U, Rosenfeld PJ (2006) Promising new treatments for neovascular age-related macular degeneration. Expert Opin Investig Drugs 15(7):779–793

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Eye Hospital, Centre for Ophthalmology, Eberhard-Karls University of Tuebingen, Schleichstr. 12-16, 72076, Tuebingen, Germany

    Matthias Lüke, Focke Ziemssen, Karl Ulrich Bartz-Schmidt & Faik Gelisken

Authors
  1. Matthias Lüke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Focke Ziemssen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karl Ulrich Bartz-Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Faik Gelisken
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthias Lüke.

Additional information

Matthias Lüke and Focke Ziemssen contributed equally to the manuscript. The authors have no competing interests related to the manuscript.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lüke, M., Ziemssen, F., Bartz-Schmidt, K.U. et al. Quality of life in a prospective, randomised pilot-trial of photodynamic therapy versus full macular translocation in treatment of neovascular age-related macular degeneration — a report of 1 year results. Graefes Arch Clin Exp Ophthalmol 245, 1831–1836 (2007). https://doi.org/10.1007/s00417-007-0558-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-007-0558-9

Keywords

Search

Navigation